{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:44:21Z","timestamp":1781307861109,"version":"3.54.1"},"reference-count":139,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1080\/17425247.2024.2445675","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T09:24:18Z","timestamp":1736155458000},"page":"181-195","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Self-amplifying RNA virus vectors for drug delivery"],"prefix":"10.1080","volume":"22","author":[{"given":"Kenneth","family":"Lundstrom","sequence":"first","affiliation":[{"name":"PanTherapeutics","place":["Lutry, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-85395-2_9"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/mr.58.3.491-562.1994"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1291-1356"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2922607"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(89)90526-6"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.29.18060"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.6.2.135"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-0556-2-13"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.21.11605-11614.2004"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1258"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-1-18"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-003-0262-y"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-017-1486-3"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.094"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1963"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.21.11359"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.249"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/9783527838394.ch4"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415622"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301263"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/10548"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2012.62"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3102"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700300"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr962"},{"issue":"21","key":"e_1_3_4_28_1","first-page":"7861","article-title":"Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA","volume":"61","author":"Velders MP","year":"2001","unstructured":"Velders MP, McElhiney S, Cassetti MC, et al. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA. Cancer Res. 2001;61(21):7861\u20137867.","journal-title":"Cancer Res"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00558-3"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.11.002"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1487913"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00343-07"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02835-06"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302889"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.169"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001662"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0220"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.08.003"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.318"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1803"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2762"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42672"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2202"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.096"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2996"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0445"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700367"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.3171\/2020.11.FOCUS20839"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.99.4.0746"},{"key":"e_1_3_4_50_1","first-page":"317","volume-title":"Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18","author":"Yamanaka R","year":"2005","unstructured":"Yamanaka R, Xanthopoulos KG. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18, DNA Cell Biol. 2005;24:317\u2013324."},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-012-1248-y"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1618-x"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2012.33"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02700029"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008603"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01869-4"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700794"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2610"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30813"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2012.1205"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12020173"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05640-11"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2018.1434539"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.095"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.086"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz202"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70043-5"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32488-7"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01406-14"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.072"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.007"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.04.077"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.12.013"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw3163"},{"key":"e_1_3_4_75_1","unstructured":"A phase 1 randomized double-blinded placebo-controlled dose-escalation clinical trial to evaluate the safety and immunogenicity of rVSV\u0394G-LASV-GPC vaccine in adults in good General health (identifier: PACTR202106625781067): pan African clinical trial registry. 2021 [cited 2024 Sep 9]. Available from: https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=15920"},{"key":"e_1_3_4_76_1","unstructured":"Pan African Clinical Trial Registry. A phase 2 randomized double-blinded placebo-controlled clinical trial to evaluate the safety tolerability and immunogenicity of rVSV\u0394G-LASV-GPC vaccine in adults and children residing in West Africa. (Identifier: PACTR202210840719552) 2022. cited 2024 Sep 9]. Available from: https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=23666"},{"key":"e_1_3_4_77_1","unstructured":"A study to assess a new Lassa virus vaccine in healthy volunteers (identifier: PACTR202108781239363): pan African clinical trial registry. 2021 [cited 2024 Sep 11]. Available from: https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=14618"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf6348"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00048-X"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.046"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.02.053"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv019"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3920"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir349"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61117-5"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32621-6"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2017.22024"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00996-07"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61428-7"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61060-6"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.07.010"},{"key":"e_1_3_4_92_1","unstructured":"Zika-vaccine dose finding study regarding safety immunogenicity and tolerability (V186\u2013001). [cited 2024 Sep 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02996890"},{"key":"e_1_3_4_93_1","unstructured":"Safety and immunogenicity of a novel vaccine formulation MV-ZIKA-RSP (V187\u2013001). MV-ZIKA-RSP); [cited 2024 Sep 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04033068"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00126-8"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-3-749"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106597"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000513860.96393.07"},{"key":"e_1_3_4_98_1","first-page":"1369","volume-title":"Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles","author":"Brand D","year":"1998","unstructured":"Brand D, Lemiale F, Turbica I, et al. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. AIDS Res Hum Retrovir. 1998;14:1369\u20131377."},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01799-07"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00258-12"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020149"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03246-14"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0155-z"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1086\/319857"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.017"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.09.009"},{"key":"e_1_3_4_107_1","unstructured":"A phase 1\/2 clinical trial on an alphavirus replicon vaccine for influenza. [cited 2024 Sep 19]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00440362"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014468117"},{"key":"e_1_3_4_109_1","unstructured":"Clinical trial to evaluate the safety and immunogenicity of the COVID-19 vaccine (COVID-19-101). [cited 2024 Sep 19]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04497298"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.07.018"},{"key":"e_1_3_4_111_1","unstructured":"Dose ranging trial to assess safety and immunogenicity of V590 (COVID-19 vaccine) in healthy adults (V590\u2013001). [cited 2024 Sep 19]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04569786"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20228-7"},{"key":"e_1_3_4_113_1","unstructured":"Evaluate the safety immunogenicity and potential efficacy of an rVSV-SARS-CoV-2-S vaccine. [cited 2024 Sep 19]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04608305"},{"key":"e_1_3_4_114_1","unstructured":"Phase 2b\/3 trial of VSV-\u0394G SARS-CoV-2 vaccine (BRILIFE) against approved comparator vaccine. [cited 2024 Sep 19]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04990466"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719077"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17409-9"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101262"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.28.121640"},{"key":"e_1_3_4_119_1","unstructured":"Safety tolerability and immunogenicity of the candidate GEMCOVAC-19 (COVID-19) vaccine in healthy pediatric subjects of 5 to less than 18 years. [cited 2024 Sep 21]. Available from: www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=66638"},{"key":"e_1_3_4_120_1","unstructured":"HDT bio receives emergency use approval for covid-19 vaccine in India. [cited 2024 Sep 21]. Available from: www.pharmaceutical-technology.com\/news\/hdt-bio-vaccine-india-approval"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.04.001"},{"key":"e_1_3_4_122_1","unstructured":"Arthur R. Arcturus\u2019 self-amplifying COVID-19 mRNA vaccine meets phase 3 primary end points. 2022 [cited 2024 Sep 21]. Available from: www.biopharma-reporter.com"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00173-09"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.07.012"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2008.11.016"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2001.00951.x"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.8.6907-6910.1998"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1080\/01459740.2012.679981"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02275-1"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13876"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1184575"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14531"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2021.101749"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2003.09.010"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01491.x"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.02.026"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1994.1216"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.09.038"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0893-916"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.2.1092-1098.1999"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2667"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2024.2445675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T19:51:30Z","timestamp":1743105090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2024.2445675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1080\/17425247.2024.2445675"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2024.2445675","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}